View in EDS

Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers.

Saved in:
Bibliographic Details
Title: Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers.
Authors: Cecchi M; Cognision, KY, USA. Electronic address: mcecchi@cognision.com., Adachi M; Astellas Pharma, CA, USA., Basile A; Merck & Co., Inc., Kenilworth, NJ, USA., Buhl DL; Takeda Pharmaceuticals, MA, USA., Chadchankar H; Novartis, MA, USA., Christensen S; Lundbeck, Denmark., Christian E; Gilgamesh Pharmaceuticals, NY, USA., Doherty J; Sage Therapeutics, MA, USA., Fadem KC; Cognision, KY, USA., Farley B; Sage Therapeutics, MA, USA., Forman MS; Passage Bio, PA, USA., Honda S; Astellas Pharma, CA, USA., Johannesen J; Sage Therapeutics, MA, USA., Kinon BJ; Cyclerion Therapeutics, MA, USA., Klamer D; Anavex Life Sciences Corp., NY, USA., Marino MJ; Merck & Co., Inc., Kenilworth, NJ, USA., Missling C; Anavex Life Sciences Corp., NY, USA., O'Donnell P; Sage Therapeutics, MA, USA., Piser T; Onsero Therapeutics, MA, USA., Puryear CB; Praxis Precision Medicines, MA, USA., Quirk MC; Sage Therapeutics, MA, USA., Rotte M; Novartis, MA, USA., Sanchez C; Alkermes, MA, USA., Smith DG; Alkermes, MA, USA., Uslaner JM; Merck & Co., Inc., Kenilworth, NJ, USA., Javitt DC; Columbia University, NY, USA., Keefe RSE; VeraSci, NC, USA., Mathalon D; University of California, San Francisco, CA, USA., Potter WZ; Independent Consultant, Philadelphia, PA, USA., Walling DP; CenExel Research, USA., Ereshefsky L; CenExel Research, USA; University of Texas Health Science Center at San Antonio, TX, USA.
Source: Schizophrenia research [Schizophr Res] 2023 Apr; Vol. 254, pp. 178-189. Date of Electronic Publication: 2023 Mar 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Publisher B. V Country of Publication: Netherlands NLM ID: 8804207 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2509 (Electronic) Linking ISSN: 09209964 NLM ISO Abbreviation: Schizophr Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36921403
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cecchi+M%22">Cecchi M</searchLink>; Cognision, KY, USA. Electronic address: mcecchi@cognision.com.<br /><searchLink fieldCode="AU" term="%22Adachi+M%22">Adachi M</searchLink>; Astellas Pharma, CA, USA.<br /><searchLink fieldCode="AU" term="%22Basile+A%22">Basile A</searchLink>; Merck & Co., Inc., Kenilworth, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Buhl+DL%22">Buhl DL</searchLink>; Takeda Pharmaceuticals, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chadchankar+H%22">Chadchankar H</searchLink>; Novartis, MA, USA.<br /><searchLink fieldCode="AU" term="%22Christensen+S%22">Christensen S</searchLink>; Lundbeck, Denmark.<br /><searchLink fieldCode="AU" term="%22Christian+E%22">Christian E</searchLink>; Gilgamesh Pharmaceuticals, NY, USA.<br /><searchLink fieldCode="AU" term="%22Doherty+J%22">Doherty J</searchLink>; Sage Therapeutics, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fadem+KC%22">Fadem KC</searchLink>; Cognision, KY, USA.<br /><searchLink fieldCode="AU" term="%22Farley+B%22">Farley B</searchLink>; Sage Therapeutics, MA, USA.<br /><searchLink fieldCode="AU" term="%22Forman+MS%22">Forman MS</searchLink>; Passage Bio, PA, USA.<br /><searchLink fieldCode="AU" term="%22Honda+S%22">Honda S</searchLink>; Astellas Pharma, CA, USA.<br /><searchLink fieldCode="AU" term="%22Johannesen+J%22">Johannesen J</searchLink>; Sage Therapeutics, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kinon+BJ%22">Kinon BJ</searchLink>; Cyclerion Therapeutics, MA, USA.<br /><searchLink fieldCode="AU" term="%22Klamer+D%22">Klamer D</searchLink>; Anavex Life Sciences Corp., NY, USA.<br /><searchLink fieldCode="AU" term="%22Marino+MJ%22">Marino MJ</searchLink>; Merck & Co., Inc., Kenilworth, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Missling+C%22">Missling C</searchLink>; Anavex Life Sciences Corp., NY, USA.<br /><searchLink fieldCode="AU" term="%22O'Donnell+P%22">O'Donnell P</searchLink>; Sage Therapeutics, MA, USA.<br /><searchLink fieldCode="AU" term="%22Piser+T%22">Piser T</searchLink>; Onsero Therapeutics, MA, USA.<br /><searchLink fieldCode="AU" term="%22Puryear+CB%22">Puryear CB</searchLink>; Praxis Precision Medicines, MA, USA.<br /><searchLink fieldCode="AU" term="%22Quirk+MC%22">Quirk MC</searchLink>; Sage Therapeutics, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rotte+M%22">Rotte M</searchLink>; Novartis, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sanchez+C%22">Sanchez C</searchLink>; Alkermes, MA, USA.<br /><searchLink fieldCode="AU" term="%22Smith+DG%22">Smith DG</searchLink>; Alkermes, MA, USA.<br /><searchLink fieldCode="AU" term="%22Uslaner+JM%22">Uslaner JM</searchLink>; Merck & Co., Inc., Kenilworth, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Javitt+DC%22">Javitt DC</searchLink>; Columbia University, NY, USA.<br /><searchLink fieldCode="AU" term="%22Keefe+RSE%22">Keefe RSE</searchLink>; VeraSci, NC, USA.<br /><searchLink fieldCode="AU" term="%22Mathalon+D%22">Mathalon D</searchLink>; University of California, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Potter+WZ%22">Potter WZ</searchLink>; Independent Consultant, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Walling+DP%22">Walling DP</searchLink>; CenExel Research, USA.<br /><searchLink fieldCode="AU" term="%22Ereshefsky+L%22">Ereshefsky L</searchLink>; CenExel Research, USA; University of Texas Health Science Center at San Antonio, TX, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228804207%22">Schizophrenia research</searchLink> [Schizophr Res] 2023 Apr; Vol. 254, pp. 178-189. <i>Date of Electronic Publication: </i>2023 Mar 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publisher+B%2E+V%22">Elsevier Science Publisher B. V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8804207 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-2509 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209209964%22">09209964 </searchLink><i>NLM ISO Abbreviation: </i>Schizophr Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36921403
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.schres.2023.02.018
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 178
    Titles:
      – TitleFull: Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cecchi M
      – PersonEntity:
          Name:
            NameFull: Adachi M
      – PersonEntity:
          Name:
            NameFull: Basile A
      – PersonEntity:
          Name:
            NameFull: Buhl DL
      – PersonEntity:
          Name:
            NameFull: Chadchankar H
      – PersonEntity:
          Name:
            NameFull: Christensen S
      – PersonEntity:
          Name:
            NameFull: Christian E
      – PersonEntity:
          Name:
            NameFull: Doherty J
      – PersonEntity:
          Name:
            NameFull: Fadem KC
      – PersonEntity:
          Name:
            NameFull: Farley B
      – PersonEntity:
          Name:
            NameFull: Forman MS
      – PersonEntity:
          Name:
            NameFull: Honda S
      – PersonEntity:
          Name:
            NameFull: Johannesen J
      – PersonEntity:
          Name:
            NameFull: Kinon BJ
      – PersonEntity:
          Name:
            NameFull: Klamer D
      – PersonEntity:
          Name:
            NameFull: Marino MJ
      – PersonEntity:
          Name:
            NameFull: Missling C
      – PersonEntity:
          Name:
            NameFull: O'Donnell P
      – PersonEntity:
          Name:
            NameFull: Piser T
      – PersonEntity:
          Name:
            NameFull: Puryear CB
      – PersonEntity:
          Name:
            NameFull: Quirk MC
      – PersonEntity:
          Name:
            NameFull: Rotte M
      – PersonEntity:
          Name:
            NameFull: Sanchez C
      – PersonEntity:
          Name:
            NameFull: Smith DG
      – PersonEntity:
          Name:
            NameFull: Uslaner JM
      – PersonEntity:
          Name:
            NameFull: Javitt DC
      – PersonEntity:
          Name:
            NameFull: Keefe RSE
      – PersonEntity:
          Name:
            NameFull: Mathalon D
      – PersonEntity:
          Name:
            NameFull: Potter WZ
      – PersonEntity:
          Name:
            NameFull: Walling DP
      – PersonEntity:
          Name:
            NameFull: Ereshefsky L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2023 Apr
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1573-2509
          Numbering:
            – Type: volume
              Value: 254
          Titles:
            – TitleFull: Schizophrenia research
              Type: main
ResultId 1